Retinal Degeneration 3 (RD3) Peptide
RD3
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all RD3 products
- RD3 (Retinal Degeneration 3 (RD3))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GQMREAERQQ RERSNAVRKV CTGVDYSWLA STPRSTYDLS PIERLQLEDV
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of RD3 antibody,
Alternative Names: RD3 control peptide, RD3 antibody Blocking Peptide, Anti-RD3 Blocking Peptide, Retinal Degeneration 3 Blocking Peptide, C1orf36 Blocking Peptide, LCA12 Blocking Peptide, RD3, RD-3, RD 3, RD-3 Blocking Peptide, RD 3 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- RD3 (Retinal Degeneration 3 (RD3))
- Background
- RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
- Molecular Weight
- 23 kDa
-
You are here:
